Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2026-03-05 @ 7:37 AM
Study NCT ID:
NCT00686595
Status:
COMPLETED
Last Update Posted:
2023-08-09
First Post:
2008-05-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133)
Sponsor:
Merck Sharp & Dohme LLC
Organization: